What is the initial treatment protocol for pediatric seizures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pediatric Seizure Protocol

Initial Stabilization (0-5 Minutes)

For any pediatric seizure, immediately assess circulation, airway, and breathing (CAB), provide airway protection, administer high-flow oxygen to prevent hypoxia, and check blood glucose immediately to rule out hypoglycemia. 1, 2

Key Initial Actions:

  • Secure airway and provide 100% oxygen 1, 2
  • Establish IV or intraosseous access 3
  • Check bedside glucose immediately - hypoglycemia is a rapidly reversible cause 1, 2
  • Monitor vital signs and oxygen saturation continuously 3

First-Line Treatment: Benzodiazepines (0-5 Minutes)

Administer lorazepam 0.1 mg/kg IV (maximum 2 mg) slowly as first-line therapy for active seizures; may repeat once after at least 1 minute (maximum of 2 doses). 2

Benzodiazepine Options:

  • Lorazepam 0.1 mg/kg IV (preferred, maximum 2 mg per dose) 3, 2, 4

    • Can repeat once if seizure continues after 1 minute
    • Superior efficacy profile in network meta-analysis 4
    • Equivalent efficacy to diazepam-phenytoin combination with simpler single-drug regimen 5
  • Alternative: Diazepam 0.2 mg/kg IV (maximum dose varies by route) 3, 6

    • Less preferred than lorazepam based on comparative data 4
  • If no IV access: Midazolam (non-IV routes) 4

    • Nonintravenous midazolam shows superior efficacy to nonintravenous diazepam 4

Critical Caveat:

Monitor closely for respiratory depression, especially when benzodiazepines are combined with other sedative agents - this is the most common serious adverse effect. 2 Have airway management equipment immediately available. 3


Second-Line Treatment: If Seizures Persist (5-20 Minutes)

If seizures continue after benzodiazepine administration, immediately administer levetiracetam 40 mg/kg IV bolus (maximum 2,500 mg). 2

Alternative Second-Line Agents:

  • Fosphenytoin 18-20 mg PE/kg IV 3, 7, 6

    • Maximum rate: 2 mg PE/kg/min (or 150 mg PE/min, whichever is slower) in pediatric patients 7
    • Slower administration rate critical to avoid cardiovascular complications 7
    • Monitor for hypotension and cardiac arrhythmias during infusion 7
  • Phenobarbital 15-20 mg/kg IV over 10 minutes 3, 6

    • Strict adherence to proper administration rate essential 6

Third-Line Treatment: Refractory Status Epilepticus (20-40 Minutes)

For seizures continuing beyond 20 minutes despite first and second-line therapy, add phenobarbital 10-20 mg/kg IV (maximum 1,000 mg) and initiate continuous EEG monitoring. 2

Additional Interventions:

  • Transfer to Pediatric Intensive Care Unit (PICU) for ongoing management 2
  • Initiate continuous EEG monitoring for refractory seizures 2
  • Consider corticosteroids if indicated by underlying etiology 2
  • Prepare for possible intubation and mechanical ventilation if seizures persist 3

Fourth-Line Options (Refractory Cases):

  • Pentobarbital infusion - 92% treatment success rate but 77% risk of hypotension requiring pressors 3
  • Midazolam infusion - 80% success rate, 30% hypotension risk 3
  • Propofol infusion - 73% success rate, 42% hypotension risk 3
  • Valproic acid IV - effective in 58-83% of refractory cases 3, 8

Maintenance Therapy After Seizure Control

Once seizures are controlled, administer lorazepam 0.05 mg/kg (maximum 1 mg) IV every 8 hours for 3 doses. 2

Maintenance Options:

  • Levetiracetam 30 mg/kg IV every 12 hours or increase prophylaxis dose by 10 mg/kg (to 20 mg/kg) IV every 12 hours (maximum 1,500 mg) 2
  • Phenobarbital 1-3 mg/kg IV every 12 hours if used in acute management 2

Special Considerations

Neonatal Seizures:

  • Follow same CAB assessment and glucose check protocol 1
  • Withdrawal-associated seizures are primarily myoclonic, respond to opiates, and carry no increased long-term risk 1

Febrile Seizures (Simple):

  • No prophylactic anticonvulsant therapy recommended for simple febrile seizures (brief, generalized, single episode in 24 hours) 3
  • Antipyretics are ineffective in preventing febrile seizure recurrence 3
  • Reassure caregivers - simple febrile seizures do not cause long-term neurological damage, IQ decline, or significantly increase epilepsy risk 3

Prolonged Seizures During Treatment:

  • Seizures lasting >180 seconds on EEG should be treated with additional methohexital, diazepam, or lorazepam 3
  • Monitor for tardive seizures (late-onset seizures occurring 24-48 hours after recovery) 3

Common Pitfalls to Avoid

  1. Inadequate respiratory monitoring - benzodiazepines cause respiratory depression, especially with combination therapy 2
  2. Excessive fosphenytoin infusion rate - must not exceed 2 mg PE/kg/min in children to avoid cardiovascular collapse 7
  3. Failure to check glucose early - hypoglycemia is rapidly reversible and commonly missed 1, 2
  4. Delaying second-line therapy - if seizures persist beyond 5 minutes after benzodiazepines, immediately proceed to levetiracetam or fosphenytoin 2
  5. Using prophylactic anticonvulsants for simple febrile seizures - toxicity outweighs minimal benefits 3

References

Guideline

Management of Neonatal Seizures with Emphasis on Initial Assessment and Stabilization

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Status Epilepticus in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Lorazepam versus diazepam-phenytoin combination in the treatment of convulsive status epilepticus in children: a randomized controlled trial.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2010

Research

Management of status epilepticus in children.

Pediatrics in review, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.